Literature DB >> 28843222

Accuracy of Cervical Visual Inspection with Acetic Acid Guide for 4-Quadrant Random Cervical Biopsies by Generalzzm321990Practitioners in Women with Abnormal Pap Smears

Patrada Suwansura1, Darigar Darojn.   

Abstract

Objective: To study the performance of visual inspection with acetic acid plus 4-quadrant cervical biopsy (V4B) by general practitioners in detecting high grade cervical lesion, compared to highest histopathologic grade from the American Society for Colposcopy and Cervical Pathology American Society for Colposcopy and Cervical Pathology (ASCCP) 2013 work up guidelines. Materials and methods: Patients with abnormal cervical cytologic screening results suggesting low grade lesions underwent V4B by general practitioners followed by colposcopy on the same day bases on ASCCP 2013 guidelines. Those with Pap smears indicative of high grade lesions or cervical cancer were sent to V4B before confirmed diagnosis and and therapeutic excisional procedures.Predictive performance of V4B was evaluated against the reference diagnosis.
Results: Compared with the reference diagnosis in 100 of patients, V4B by general practitioners had sensitivity, specificity, PPV, and NPV of 67.9%, 100%, 100%, and 88.9%, respectively. There were 11.1% false negatives with no false positives. No complications were observed following this technique.
Conclusion: Overall, V4B by general practitioners demonstrates moderate accuracy when compared with definite diagnosis by colposcopy and/or LEEP. This novel strategy performed better in those with low grade lesions on cervical cytological screening. Creative Commons Attribution License

Entities:  

Keywords:  VIA; cervical biopsy; endocervical curettage; colposcopy; high grade lesion; low grade lesion

Year:  2017        PMID: 28843222      PMCID: PMC5697460          DOI: 10.22034/APJCP.2017.18.8.2063

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


Introduction

Cervical cancer is one of the most common malignancy in Thai women. The incidence of 14.4% was reported by Thai National Cancer Institute (NCI) in 2011, with 7,000 new cases annually. Despite of highly effective diagnostic procedure and treatment, mortality rate from cervical cancer remain high. It’s been known for more than 60 years that Papanicolaou (PAP) smear plays an important role in screening for cervical cancer (Gaffikin et al., 2003). Colposcopy is recommended if an abnormal cervical cytological screening occurs. As colposcopy is not available in every health-care facility, simpler diagnostic procedures may be needed. In 1982, Visual inspection with acetic acid (VIA) was introduced as an alternative technique by using 3-5% acetic acid for detecting abnormal cervical lesions is highly sensitivity as well as cost-effective, and it not need colposcopy to identify where the lesion is. (Jonathan, 2012; Kantathavorn et al., 2015).

Accuracy to study by VIA with random cervical biopsy and endocervical

Curettage (ECC) was equally effective for detection of high grade cervical lesion compared to colposcopy (Lee et al., 2012). Therefore VIA guide for 4quardant biopsy might represent an alternative to use in a more diverse healthcare settings. This setting resident was trained about VIA before start the study that not represents the real situation of general practitioners who was not trained about VIA. Now ASCCP 2013 guideline HPV DNA testing used compatibility with cytological cervical screening test that is call “Co-testing” In 2012, the prevalence of high risk Human Papillomavirus (HPV) infection is 24.15% and only 4.83% had positive PAP smear.(5) Similar study in Thailand, the prevalence of High–risk HPV infection in Thai women is 15.1 %, while the incidence of cervical cytologic abnormalities only 4.9 %.(6) Thus the patients who have positive HPV DNA more required colposcopy in the future. In the future, prevalence of abnormal Co-test will be increase so as colposcopy required. This research was desired to find procedure that could detected high grade lesion in the low resource setting. Because colposcopy need Experian hand, expensive and not available on every hospital, In the other hand we know that VIA could detect cervical lesion, not need expensive instrument, not need Experian hand and available on every hospital near the patient. The objective of this study was arrived to compare the accuracy of Visual inspection with acetic acid guide for 4 quadrants cervical biopsy (V4B) by general practitioners (who was not trained about VIA) to detected high grade cervical lesions, compare to highest histopathologic grade that come from the step of American Society for Colposcopy and Cervical Pathology American Society for Colposcopy and Cervical Pathology (ASCCP) 2013 work up guideline by gynecologic oncologist.

Materials and Methods

The patients who visited the obstetric and gynecologic department of abnormal cervical cytological screening were asked to participate in the study, either those first or repeated abnormal cervical cytological screening. Exclusion criteria included the pregnant patients, untreated abnormal uterine bleeding patients, patients who had no cervix, cervical radiation, already diagnose cervical cancer, cervical gross lesion and patients who refused to participate. Those who previously Therapeutic cervical excisions were also excluded. There were 100 patients between September to November 2014 were included. This study was approved by the ethical committee of Sappasitthiprasong Hospital.

Abnormal cervical cytological screening

Abnormal cervical cytological screening was abnormal finding from Pap smear and liquid base cytology. There were Atypical squamous cells of undetermined significant(ASC-US), Atypical squamous cells –cannot exclude HSIL(ASC-H), Low grade squamous intraepithelial lesion(LSIL), High grade squamous intraepithelial lesion(HSIL), Squamous cell carcinoma, Atypical endocervical cell(not otherwise specified(NOS)or specifiy in comments), Atypical grandular cell(NOS or specifiy in comments), Atypical endocervical cells, favor neoplastic Atypical grandular cells, favor neoplastic, Adenocarcinoma in situ(AIS), Adenocarcinoma. Divided in two group as Low grade lesion: ASC-US, LSIL, Atypical endocervical cell (not otherwise specified(NOS)or specify in comments), Atypical grandular cell(NOS or specify in comments) and High grade lesion : ASC-H, HSIL, Squamous cell carcinoma, Atypical endocervical cells, favor neoplastic, Atypical grandular cells, favor neoplastic, Adenocarcinoma in situ(AIS), Adenocarcinoma.

V4B

Visual inspection with acetic acid guide for 4 quadrants cervical biopsy means VIA with directed cervical biopsy (VDB) any quadrants if there were lesion and VIA with random cervical biopsy (VRB) in the rest of quadrants to become 4 pieces tissue

Colposcopy

Colposcpoe is a diagnostic procedure to examine an illuminated, magnified view of the cervix. A colposcope, which provides an enlarged view of the areas, and apply 3-5% acetic acid to allowing the colposcopist to visually distinguish normal from abnormal appearing tissue and take directed biopsies for further pathological examination. If do not biopsy that means normal finding.

LEEP

Loop Electrosourgical Excional Procedure used a thin low voltage wire loop to remove abnormal tissue in a woman’s cervix. It is used as part of the diagnosis and treatment. It may be performed after abnormal cells are found during a Pap test, colposcopy, or biopsy.

Reference diagnosis

A definite diagnosis base on highest histopathologic grade from either diagnostic and therapeutic excisional procedure or endocervical curettage (ECC) or colposcopic directed biopsy (CDB) or V4B whereas the step of work up guide come from ASCCP 2013 guideline, and reviews pathology was done if result of biopsy superior than excisional procedure.

Methods

The patients were classified into two group by using abnormal cervical cytologic screening; the patients with high-grade cervical cytologic screening and the patients with low-grade cervical cytologic screening lesion. High-grade lesion patients or cervical cancer were arranged for V4B by general practitioners and immediate followed by therapeutic excisional procedure by gynecologic oncologists. Low-grade lesion patients were underwent V4B by general practitioners and immediate followed by CDB plus ECC by gynecologic oncologists. Every patient was arranged to follow up for pathological results in 1-2 weeks after procedure. The patients with high-grade lesion were received diagnostic and therapeutic excisional procedure. Complication of the procedure including bleeding and infection was evaluated at 30 days after the procedure was done when the patient came back for pathological result.

Statistical Analysis

Data on dermographic data; patients age, education, occupation and Obstretric and gynecologic data; term birth, preterm birth, abortion, number of child, Route of delivery, number of sexual partners, age of first sexual intercourse, history of sexual transmitted disease and number of screening pap smear were obtained using interviewer administed questionnaire. Categorical and continuous data were presents as number (%) and mean(SD) respectively. Comparison across two groups (low grade lesion VS high grade lesion) was performed using chi square and T test respectively. P value of less than 0.05 was considered statistic significant. SPSS version 19 was used to compare between the results of V4B by general practitioner and CDB or diagnostic excisional procedure as ASCCP guideline 2013 by gynecologic oncologists. Negative predictive value, positive predictive value Sensitivity and specificity were calculated.

Sampe size

Based on the problem that the sensitivity of V4B by general practitioners in abnormal cervical cytologic screening women from the study by Pongson et el in 2011(4), P=95% confident of interval, this study want sample size 88 participants and for the error we increase the sample size 10%, overall 100

Results

Of the 100 patients have average age was 43.52±7.942 yrs (35-52 of age). The most education is primary school and the most occupation is government officer. Comparison between two groups found no significant difference, as shown in table 1.
Table 1

Demographic Data in Woman with Abnormal Cervical Cytologic Screening

TotalaLow grade lesionHigh grade lesionp-valueb
Demographic data1007327
Age (years) (mean±SD)43.5±7.943.2±7.444.5±9.40.499
Education, N(%)0.159
 - Primary43(43.0%)30(41.1%)13(48.1%)
 - Secondary17(17.0%)10(13.7%)7(25.9%)
 - diploma7(7.0%)4(5.5%)3(11.1%)
 - Bachelor degree23(23.0%)20(27.4%)3(11.1%)
 - Master degree10(10.0%)9(12.3%)1(3.7%)
Occupation, N(%)0.226
 - Housekeeper7(7.0%)3(4.1%)4(14.8%)
 - Employee11(11.0%)6(8.2%)5(18.5%)
 - Farmer28(28.0%)20(27.4%)8(29.6%)
 - Government officer34(34.0%)29(39.7%)5(18.5%)
 - Merchant7(7.0%)5(6.8%)2(7.4%)
 - Business12(12.0%)9(12.3%)3(11.1%)
 - Others1(1.0%)1(1.4%)0(0.0%)

Data are presented as mean ±SD and number(%) for categorical and continuous variable

comparison across two groups perform using chi square and T test for categorical and continuous variable respectively.

Demographic Data in Woman with Abnormal Cervical Cytologic Screening Data are presented as mean ±SD and number(%) for categorical and continuous variable comparison across two groups perform using chi square and T test for categorical and continuous variable respectively. High grade lesion patients were significant increase in number of term birth (2.37±1.24 vs 1.64±0.89, p=0.002), number of alive child (2.36±1.22 vs 1.64±0.90, p=0.007) and number of patients who diagnosed PID (4.2% vs 17.9%, p=0.023). Age of first sexual intercourse appeared to be significantly lower in high-grade lesion patients (18.39±2.71 vs 20.41±3.43, p=0.003). Whereas number of preterm birth, number of abortion, route of delivery, number of sexual partners and other history of sexual transmitted disease were not significantly different, as shown in Table 2
Table 2

Obstetric and Gynecologic Factors in Woman with Abnormal Cervical Cytologic Screening

Obstetric and gynecologic factorsTotalaLow grade lesionHigh Grade lesionp- valueb
Term birth1.84±1.041.64±0.892.37±1.240.002
Preterm birth0.01±0.100.01±0.1200.536
Abortion0.33±0.620.36±0.660.25±0.520.377
child1.84±1.041.64±0.902.36±1.220.007
Route of delivery N(%)0.489
 none11(11.0%)9(12.5%)2(7.1%)
 normal delivery82(82.0%)57(79.2%)25(89.3%)
 cesarean delivery7(7.0%)6(8.3%)1(3.8%)
Sexual partner N(%)1.67±0.821.63±0.811.79±0.830.387
Age of first sexual intercourse (yrs.)19.84±3.3520.41±3.4318.39±2.710.003
History of sexual transmitted disease N(%)
 1.fever with pelvic pain7(7.0%)3(4.2%)4(13.3%)0.075
 2.pelvic pain with abnormal vaginal discharge25(25.0%)19(26.4%)6(21.4%)0.607
 3.fever during menstrual9(9.0%)7(9.7%)2(7.1%)0.686
 4.history of PID8(8.0%)3(4.2%)5(17.9%)0.023
Number of screening pap smear5.30±3.995.44±4.054.93±3.880.558

Data are presented as mean ±SD and number(%) for categorical and continuous variable

comparison across two groups perform using chi square and T test for categorical and continuous variable respectively.

Obstetric and Gynecologic Factors in Woman with Abnormal Cervical Cytologic Screening Data are presented as mean ±SD and number(%) for categorical and continuous variable comparison across two groups perform using chi square and T test for categorical and continuous variable respectively. Abnormal cervical cytologic screening test shown in table 3, most common abnormal cytology is ASC-US (40%) and LSIL (39%).
Table 3

Result of Abnormal Cervical Cytology.

Abnormal cytologyN (%)
ASC-US40 (40%)
ASC-H5 (5%)
AGC3 (3%)
LSIL39 (39%)
HSIL13 (13%)
Total100 (100%)
Result of Abnormal Cervical Cytology. Pathology of reference diagnosis shown in Table 4, most frequent is normal (38%), followed by LSIL (31%) HSIL (25%) cervical carcinoma(3%) and cervicitis(3%)
Table 4

Pathology of Reference Diagnosis

Reference diagnosisN (%)
Normal38 (38%)
Cervicitis3 (3%)
LSIL31 (31%)
HSIL25 (25%)
Cervical carcinoma3 (3%)
Total100 (100%)
Pathology of Reference Diagnosis Showing in Table 5, V4B plus ECC by general practitioner could detected 19 out of 28 high-grade lesion patients. It came to a sensitivity of 67.9%, specificity of 100%, positive predictive value of 100% and negative predictive value of 88.9%, with false-negative of 11.1% and no false-positive.
Table 5

Compare between V4B Plus ECC by General Practitioner and Reference Diagnosis

reference diagnosisTotal
Low grade lesionHigh grade lesionCases (%)
V4B by GPLow grade Lesion72981 (100%)
High grade lesion01919 (100%)
Total7228100
Compare between V4B Plus ECC by General Practitioner and Reference Diagnosis Showing in Table 6, In subgroup of low grade cervical cytologic screening patients, V4B by general practitioner could detected 3 out of 13 high-grade lesion patients. It came to a sensitivity of 76.9%, specificity of 100%, positive predictive value of 100% and negative predictive value of 95.7%, with false-negative of 4.4% and no false-positive.
Table 6

In Subgroup of Low Grade Cervical Cytologic Screening Patients to be Compare between V4B Plus ECC by General Practitioner and Reference Diagnosis

Tota Cases(%)reference diagnosis
Low grade lesionHigh grade lesion
V4B by general practitionersLow grade lesion66369 (100%)
High grade lesion01010 (100%)
Total661379 (100%)
In Subgroup of Low Grade Cervical Cytologic Screening Patients to be Compare between V4B Plus ECC by General Practitioner and Reference Diagnosis No complication following procedures performed by general practitioner was observed after 30 days of study

Discussion

The obstetrics and gynecologic data of the participants shown that multiparity, younger age of first sexual intercourse and history of pelvic inflammatory disease more associate with high grade lesion as known as risk of cervical cancer. V4B in which performed by general practitioners showed sensitivity of 67.9% and negative predictive value of 88.9%, but specificity and positive predictive value of 100%. Focusing in low-grade cervical cytological screening test patients showed negative predictive value of 95.7% and sensitivity of 76.9%, and specificity and positive predictive value remained 100%. The accuracy of V4B by general practitioners to detected high grade lesion was higher in setting of low grade cervical cytologic screening patients. Because the study population was very close to Puntachai Pongson study (Lee et al., 2012) but sensitivity of V4B by general practitioners to detected high grade lesion was lower 67.9% vs that cause by variation of operators, so we believe that training for VIA can improve sensitivity of V4B The diagnostic accuracy of this technique improved in those with low grade cervical cytologic screening (sensitivity of 76% and false negative of 4.3%). Anyway, the study has show that the procedure of V4B by general practitioners who had not train for VIA, in which possibly done in setting of primary and secondary care units, has less effective accuracy and outcome when comparing with diagnosis by ASCCP guideline 2013.

Limitation

If pap smear and CDB and V4B and ECC show low grade lesion all step, due to ethical issue we not done LEEP. After LEEP, there was more risk of cervical infection, bleeding, cervical stenosis that can cause hematometra or infertility, cervical incompetent and higher risk of preterm birth. Therefore if cytological or histopathological results show low grade lesion, we not done LEEP by the reason of ethic. By theoretical LEEP should be the best answer but in these situation ASCCP 2013 guidline not recommended.
  5 in total

1.  Examination of the cervix with the naked eye using acetic acid test.

Authors:  M Ottaviano; P La Torre
Journal:  Am J Obstet Gynecol       Date:  1982-05-15       Impact factor: 8.661

2.  Comparing visual inspection with acetic acid plus random cervical biopsy plus endocervical curettage to colposcopic directed biopsy plus endocervical curettage in detecting cervical lesions in low-resource settings.

Authors:  Pongsun Puntachai; Darigar Darojn; Bandit Chumworathayi; Wichian Chaousriku
Journal:  Asian Pac J Cancer Prev       Date:  2011

3.  Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: a demonstration project.

Authors:  L Gaffikin; P D Blumenthal; M Emerson; K Limpaphayom
Journal:  Lancet       Date:  2003-03-08       Impact factor: 79.321

4.  High-risk human papillomavirus infection in low risk women: incidence, patient characteristics, and clinical meaning for cervical cancer.

Authors:  Sung Jong Lee; Seung Geun Yeo; Dong Choon Park
Journal:  Int J Med Sci       Date:  2011-12-15       Impact factor: 3.738

5.  Genotypic distribution of human papillomavirus (HPV) and cervical cytology findings in 5906 Thai women undergoing cervical cancer screening programs.

Authors:  Nuttavut Kantathavorn; Chulabhorn Mahidol; Narongrit Sritana; Thaniya Sricharunrat; Natacha Phoolcharoen; Chirayu Auewarakul; Narongchai Teerayathanakul; Chantanee Taepisitpong; Siriporn Saeloo; Gaidganok Sornsamdang; Wandee Udomchaiprasertkul; Waraphorn Krongthong; Arpaporn Arnamwong
Journal:  Infect Agent Cancer       Date:  2015-03-02       Impact factor: 2.965

  5 in total
  1 in total

1.  Evaluation of the effectiveness of high-risk human papilloma self-sampling test for cervical cancer screening in Bolivia.

Authors:  Gustavo Allende; Pedro Surriabre; Neli Ovando; Pamela Calle; Andrea Torrico; Jaime Villarroel; Michel Bossens; Véronique Fontaine; Patricia Rodriguez
Journal:  BMC Infect Dis       Date:  2020-04-03       Impact factor: 3.090

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.